Author: PRNW Agency
-
IKEA brings miniature homes to three cities to show how small changes can go a long way
MALMÖ, Sweden, Sept. 3, 2026 /PRNewswire/ — A series of handcrafted miniature homes appear in Melbourne, Chengdu and Beijing to mark the launch of IKEA open house, an in-store experience showing how small, affordable changes can help people make more room for what they love. …
-

Zendure Introduces Agentic HEMS at IFA 2026: "The Home Energy Hub of the AI Era"
Zendure moves home energy beyond AI scheduling to a system-level intelligence that can predict, plan, and act on its own — powered by the proprietary ZenPulse forecasting model, ZENKI™ AI Agents, and the open Zen+OS platform.BERLIN, Sept. 3, 2026 /PRNewswire/ — Zendure, a global pioneer of plug-in …
-

AssetPlus Launches Portfolio Management Services to Help MFD Partners Grow and Retain High-Net-Worth Clients
AssetPlus is the first platform in India to give MFD partners daily portfolio updates for their PMS clients.CHENNAI, India, Sept. 3, 2026 /PRNewswire/ — AssetPlus, a fully digital wealth management platform designed for India’s Mutual Fund Distributors (MFDs), has launched Portfolio Management Serv…
-

Bybit Names Sean Ballard as Head of Derivatives and Institutional Business Amid Continued Institutional Expansion
DUBAI, UAE, Sept. 2, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to announce the appointment of Sean Ballard as Head of Derivatives and Institutional Business. Ballard will play a central role in strengthening the exchange’s trading in…
-

Helfie AI Appoints John Rego as Chief Financial Officer
Veteran CFO with more than $10 billion raised across six public and private companies joins Helfie AI to lead financial strategyMELBOURNE, Australia, Sept. 2, 2026 /PRNewswire/ — Helfie AI (“Helfie”), an AI-powered preventative network transforming global healthcare by delivering personalised scree…
-

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I., Sept. 2, 2026 /PRNewswire/ — EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the immunogenicity risk of biotherapeutics. The release introduces an updated JanusMatrix™ model, a refined tolerance…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.








